Evorel Conti is a continuous combined HRT patch containing estradiol and norethisterone acetate. It provides both hormones throughout treatment and is changed twice weekly. Suitability depends on your menopause stage and medical history.
Continuous combined HRT
Evorel Conti supplies oestrogen and a progestogen in each patch. It is used after menopause when a continuous combined regimen is appropriate. The progestogen helps protect the womb lining from the effects of oestrogen.
It is not the same as oestrogen-only Evorel or sequential Evorel Sequi. Tell the prescriber when your last period occurred and which HRT you currently use.
Dose and available pack sizes
Each patch releases 50 micrograms of estradiol and 170 micrograms of norethisterone acetate per 24 hours. Select 1 × 8, 2 × 8 or 3 × 8 patches to see the private price.
At the usual twice-weekly schedule, eight patches cover four weeks. Your actual regimen and repeat supply are confirmed by the clinician. The photograph is an example carton; multi-carton orders contain the selected total quantity.
Using Evorel Conti
Apply patches to the trunk below the waist and rotate the site. Keep to your two change days each week. A patch can usually remain on during bathing or showering; follow the leaflet if it comes off.
The continuous regimen is intended to avoid a scheduled monthly withdrawal bleed, but spotting may happen. Unexpected or persistent bleeding needs assessment.
Choosing between HRT preparations
Evorel Sequi uses different patches in two phases, while Evorel supplies oestrogen alone. A patch is not automatically more suitable because it avoids tablets; individual benefits and risks still need review.
Your menopause assessment
Use our menopause consultation to discuss symptoms, existing HRT and the treatment you would prefer. A clinician reviews suitability before prescribing. Choosing a product does not guarantee supply. Tell the team about unexpected bleeding, your last period, any hysterectomy and all medicines you use.
HRT is not contraception. If pregnancy is still possible, ask about appropriate contraception. Do not change between HRT preparations or add hormones without advice.
Information checked on 28 October 2026 against Evorel Conti patient leaflet, Evorel Conti prescribing information and NHS HRT guidance. Always read the leaflet supplied with your medicine.












